Complement deficiencies in humans and animals: Links to autoimmunity

被引:67
作者
Lewis, M. J. [1 ]
Botto, M. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Med, Rheumatol Sect, London W12 0NN, England
基金
英国惠康基金;
关键词
complement deficiency; systemic lupus erythematosus; apoptosis; tolerance;
D O I
10.1080/08916930600739233
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Complement is involved in the pathogenesis of systemic lupus erythematosus (SLE) in multiple ways and may act as both friend and foe. Inherited homozygous deficiency of one of the earliest components of the classical pathway is strongly associated with susceptibility to the development of SLE. However, complement is also implicated in the effector inflammatory phase of the autoimmune response that characterizes the disease. A further paradox in the links between complement and SLE is the observation that autoantibodies to some complement proteins, especially to C1q, develop as part of the autoantibody response. In this chapter, the role of the complement system in SLE is reviewed and hypotheses advanced to explain the complex relationships between complement and lupus.
引用
收藏
页码:367 / 378
页数:12
相关论文
共 126 条
[1]  
AGNELLO V, 1978, ARTHRITIS RHEUM, V21, P146
[2]   Dendritic cells acquire antigen from apoptotic cells and induce class I restricted CTLs [J].
Albert, ML ;
Sauter, B ;
Bhardwaj, N .
NATURE, 1998, 392 (6671) :86-89
[3]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[4]   Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus - Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity [J].
Amoura, Z ;
Piette, JC ;
Chabre, H ;
Cacoub, P ;
Papo, T ;
Wechsler, B ;
Bach, JF ;
Koutouzov, S .
ARTHRITIS AND RHEUMATISM, 1997, 40 (12) :2217-2225
[5]   Autoimmunity through cytokine-induced dendritic cell activation [J].
Banchereau, J ;
Pascual, V ;
Palucka, AK .
IMMUNITY, 2004, 20 (05) :539-550
[6]  
Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO
[7]  
2-K
[8]   Molecular, genetic and epidemiologic studies on selective complete C1q deficiency in Turkey [J].
Berkel, AI ;
Birben, E ;
Öner, C ;
Öner, R ;
Loos, M ;
Petry, F .
IMMUNOBIOLOGY, 2000, 201 (3-4) :347-355
[9]   Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM [J].
Boes, M ;
Schmidt, T ;
Linkemann, K ;
Beaudette, BC ;
Marshak-Rothstein, A ;
Chen, JZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1184-1189
[10]   Requirement of dying cells and environmental adjuvants for the induction of autoimmunity [J].
Bondanza, A ;
Zimmermann, VS ;
Dell'Antoni, G ;
Dal Cin, E ;
Balestrieri, G ;
Tincani, A ;
Amoura, Z ;
Piette, JC ;
Sabbadini, MG ;
Rovere-Querini, P ;
Manfredi, AA .
ARTHRITIS AND RHEUMATISM, 2004, 50 (05) :1549-1560